Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
doctor in handcuffs after being arrested

Twin doctors plead guilty in $45M insurance fraud scheme

Desi Barroga and Deno Barroga allegedly prescribed opiates to patients in exchange for false statements to insurers.

Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

the words "FDA recall" on a board

Dozens of injuries trigger FDA recall of over 50,000 implantable tissue marking devices

The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.  

BioZorb 3D bioabsorbable marker Hologic

Hologic recalling breast care devices after 71 injuries, FDA says

UPDATED: The alert pertains to the BioZorb and BioZorb LP radiographic markers, implanted in soft tissue to indicate the site for radiation therapy or other medical procedures. 

doctor examines patient data on their tablet

AVR for moderate AS: New 10-year data highlight clear benefits of TAVR, surgery

New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone. 

healthcare value value-based care money dollar

Aetna declines to modify payment policy despite pleas from radiology societies

ACR, the Society of Interventional Radiology and others believe these restrictions will force patients to consider problematic alternatives for their back pain, such as opioids. 
 

Medicare Advantage Part C clipboard payment

Radiology provider joins growing number of institutions refusing to accept Medicare Advantage

“Medicare Advantage undermines my expertise as a physician and disregards my patients’ unique medical needs," said radiation oncologist Todd E. Hlavaty, MD. 

Women remain underrepresented in revascularization trials—can cardiology leaders reverse that trend?

“If together we do not just hope for, but demand, adequate representation as a necessary criterion for high-quality studies worthy of adoption into practice, we will have a real shot at achieving true equity in our trials," cardiologists said in a new commentary.

Displaying 1313 - 1320 of 4415
Design by Adaptive Theme